NanoViricides, Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $2.8M | $1.6M | $4.8M | $8.1M | $14.1M | $20.5M | $13.7M | $2.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $3.2M | $1.7M | $5.0M | $8.4M | $14.4M | $20.8M | $14.0M | $2.8M |
| Property, Plant & Equipment | $6.4M | $6.8M | $7.5M | $8.1M | $8.7M | $9.1M | $9.5M | $10.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $308.8K | $317.0K | $325.3K | $333.6K | $341.8K | $350.1K | $358.4K | $366.7K |
| Total Assets | $9.9M | $8.8M | $12.8M | $16.9M | $23.5M | $30.3M | $23.9M | $13.4M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | $58.0K | $200.0K | $380.7K | $309.9K |
| Total Current Liabilities | $1.2M | $1.3M | $1.4M | $534.3K | $412.8K | $351.1K | $2.2M | $2.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.2M | $1.3M | $1.4M | $2.0M | $412.8K | $351.1K | $2.2M | $2.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-157.1M | $-148.8M | $-139.4M | $-131.1M | $-122.5M | $-114.4M | $-105.6M | $-92.1M |
| Total Stockholders' Equity | $8.7M | $7.5M | $11.5M | $14.9M | $23.1M | $29.9M | $21.8M | $10.6M |